Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Laboratorio Farmaceutico Erfo SpA EV-to-EBITDA?
Laboratorio Farmaceutico Erfo SpAMIL:ERFO 68 EV-to-EBITDA is 5.27 as of Aug. 05, 2026, which is 14% below its 10-year median of 6.15. GuruFocus rates MIL:ERFO with a GF Score™ of 68/100 and a GF Value™ of €2.14 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 1,641 Consumer Packaged Goods companies, Laboratorio Farmaceutico Erfo SpA ranks better than 78.79% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Laboratorio Farmaceutico Erfo SpA's enterprise value is €10.62 Mil.
Laboratorio Farmaceutico Erfo SpA's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €2.02 Mil. Therefore, Laboratorio Farmaceutico Erfo SpA's EV-to-EBITDA for today is 5.27.
The historical rank and industry rank for Laboratorio Farmaceutico Erfo SpA's EV-to-EBITDA or its related term are showing as below:
MIL:ERFO'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.14 Med: 6.15 Max: 14.04
Current: 5.27
During the past 7 years, the highest EV-to-EBITDA of Laboratorio Farmaceutico Erfo SpA was 14.04. The lowest was 4.14. And the median was 6.15.
MIL:ERFO's EV-to-EBITDA is ranked better than 78.79% of 1641
companies
in the Consumer Packaged Goods industry
Industry Median: 9.03
vs MIL:ERFO: 5.27
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Laboratorio Farmaceutico Erfo SpA's PE Ratio (TTM) for today is calculated as:
Laboratorio Farmaceutico Erfo SpA's share price for today is €1.175.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Laboratorio Farmaceutico Erfo SpA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.044.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:ERFO vs KHC, GIS, HRL: EV-to-EBITDA Comparison
For the Packaged Foods subindustry, Laboratorio Farmaceutico Erfo SpA's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Laboratorio Farmaceutico Erfo SpA EV-to-EBITDA vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Laboratorio Farmaceutico Erfo SpA's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Laboratorio Farmaceutico Erfo SpA's EV-to-EBITDA falls into.
Laboratorio Farmaceutico Erfo SpA's current Enterprise Value is €10.62 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Laboratorio Farmaceutico Erfo SpA's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €2.02 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) has a EV-to-EBITDA of 5.27 as of Aug. 05, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Laboratorio Farmaceutico Erfo SpA. This is 14% below median its historical median of 6.15. Over the past decade, Laboratorio Farmaceutico Erfo SpA's EV-to-EBITDA has ranged from 4.14 to 14.04. According to the industry distribution chart, Laboratorio Farmaceutico Erfo SpA ranks #348 out of 1641 companies in the Consumer Packaged Goods industry, placing it in the top 21.2%.
Is Laboratorio Farmaceutico Erfo SpA's EV-to-EBITDA too high?
Laboratorio Farmaceutico Erfo SpA's current EV-to-EBITDA of 5.27 is 14% below median its 10-year median of 6.15. Over the past 10 years, this metric has ranged from a low of 4.14 to a high of 14.04. The Consumer Packaged Goods industry median EV-to-EBITDA is 9.03. Laboratorio Farmaceutico Erfo SpA's value of 5.27 is 41.6% below this industry median. Based on the distribution chart, Laboratorio Farmaceutico Erfo SpA ranks #348 out of 1641 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Laboratorio Farmaceutico Erfo SpA has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Laboratorio Farmaceutico Erfo SpA's EV-to-EBITDA compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Laboratorio Farmaceutico Erfo SpA ranks #348 out of 1641 companies for EV-to-EBITDA. This places Laboratorio Farmaceutico Erfo SpA in the top 21% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 9.03. Laboratorio Farmaceutico Erfo SpA's value of 5.27 is 41.6% below this benchmark. Historically, Laboratorio Farmaceutico Erfo SpA's own EV-to-EBITDA has ranged from 4.14 to 14.04 over the past decade. While the company's 10-year median is 6.15 vs. the industry median of 9.03, Laboratorio Farmaceutico Erfo SpA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Consumer Packaged Goods company?
The median EV-to-EBITDA among Consumer Packaged Goods companies is 9.03, based on 1,641 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Laboratorio Farmaceutico Erfo SpA's current EV-to-EBITDA of 5.27 is 41.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Laboratorio Farmaceutico Erfo SpA. For the Consumer Packaged Goods industry, the median EV-to-EBITDA is 9.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Laboratorio Farmaceutico Erfo SpA's current EV-to-EBITDA is 5.27, which is 14% below median its own 10-year median of 6.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laboratorio Farmaceutico Erfo SpA stock overvalued right now?
Based on GuruFocus' analysis, Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) is currently considered Significantly Undervalued. The stock's GF Value™ is €2.14, compared to a current price of €1.18 — trading 45.1% below its estimated fair value. The current EV-to-EBITDA is 5.27, which is 14% below median its 10-year median of 6.15 and 41.6% below the Consumer Packaged Goods industry median of 9.03. Laboratorio Farmaceutico Erfo SpA's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Laboratorio Farmaceutico Erfo SpA (MIL:ERFO), the current EV-to-EBITDA is 5.27 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) Overvalued in 2026?
Based on GuruFocus' analysis, Laboratorio Farmaceutico Erfo SpA stock appears to be undervalued.
The current stock price of €1.18 is trading 45.1% below its estimated GF Value™ of €2.14.
GuruFocus considers Laboratorio Farmaceutico Erfo SpA to be Significantly Undervalued.
Key valuation signals for MIL:ERFO:
EV-to-EBITDA: 5.27 (14% below median its 10-year median of 6.15)
GF Value™: €2.14 vs. price of €1.18 (45.1% below fair value)
Industry Position: 41.6% below the Consumer Packaged Goods median (#348 of 1641)
No single metric tells the full story. See the MIL:ERFO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.
68GF Score
Get the complete analysis for MIL:ERFO
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:ERFO has been successfully added to your 
